Replimune Appoints Dieter Weinand as Chairman and Paolo Pucci to the Board of Directors

    NEXT STORY
    Helix BioPharma Corp. Provides Corporate Update
    PREV STORY
    Affimed Provides COVID-19-Related Business Update and Announces Full Year 2019 Financial Results Conference Call on April 28, 2020
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Corvus Pharmaceuticals Names Jason V. Coloma to Newly Created Post of Chief Business Officer

    BURLINGAME, Calif., June 29, 2016 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS), a clinical-stage ...

    author_avatar
    NASDAQ Market News

    NANOBIOTIX : Résultats semestriels au 30 juin 2018

       Résultats semestriels au 30 juin 2018 Etapes majeures réalisées grâce au succès de ...

    author_avatar
    NASDAQ Market News

    AngioDynamics to Report Fiscal 2017 First Quarter Financial Results

    ALBANY, N.Y., Sept. 21, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, ...

    author_avatar
    NASDAQ Market News